Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HeXun Biosciences CoROCO:6986 -1.30%42 OCF Margin % is 41.91% as of Jun. 2026, which is 11% above its 10-year median of 37.61. GuruFocus rates ROCO:6986 with a GF Score™ of 42/100 and a GF Value™ of NT$109.27 (Significantly Undervalued). Among 957 Biotechnology companies, HeXun Biosciences Co ranks better than 96.34% on this metric.
The historical data trend for HeXun Biosciences Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6986 vs VRTX, REGN, RVMD: OCF Margin % Comparison
For the Biotechnology subindustry, HeXun Biosciences Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeXun Biosciences Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where HeXun Biosciences Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeXun Biosciences Co (ROCO:6986) has a OCF Margin % of 41.91% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on HeXun Biosciences Co and its competitors. This is 11% above median its historical median of 37.61. Over the past decade, HeXun Biosciences Co's OCF Margin % has ranged from 22.70 to 55.89. According to the industry distribution chart, HeXun Biosciences Co ranks #35 out of 957 companies in the Biotechnology industry, placing it in the top 3.7%.
Is HeXun Biosciences Co's OCF Margin % too high?
HeXun Biosciences Co's current OCF Margin % of 41.91% is 11% above median its 10-year median of 37.61. Over the past 10 years, this metric has ranged from a low of 22.70 to a high of 55.89. Based on the distribution chart, HeXun Biosciences Co ranks #35 out of 957 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, HeXun Biosciences Co has a GF Score™ of 42/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HeXun Biosciences Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, HeXun Biosciences Co ranks #35 out of 957 companies for OCF Margin %. This places HeXun Biosciences Co in the top 4% of its industry — outperforming the majority of peers. Historically, HeXun Biosciences Co's own OCF Margin % has ranged from 22.70 to 55.89 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on HeXun Biosciences Co and its competitors. HeXun Biosciences Co's current OCF Margin % is 41.91%, which is 11% above median its own 10-year median of 37.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeXun Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, HeXun Biosciences Co (ROCO:6986) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$109.27, compared to a current price of NT$41.75 — trading 61.8% below its estimated fair value. The current OCF Margin % is 41.91%, which is 11% above median its 10-year median of 37.61. HeXun Biosciences Co's overall GF Score™ is 42/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For HeXun Biosciences Co (ROCO:6986), the current OCF Margin % is 41.91% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HeXun Biosciences Co (ROCO:6986) Overvalued in 2026?
Based on GuruFocus' analysis, HeXun Biosciences Co stock appears to be undervalued.
The current stock price of NT$41.75 is trading 61.8% below its estimated GF Value™ of NT$109.27.
GuruFocus considers HeXun Biosciences Co to be Significantly Undervalued.
Key valuation signals for ROCO:6986:
OCF Margin %: 41.91% (11% above median its 10-year median of 37.61)
GF Value™: NT$109.27 vs. price of NT$41.75 (61.8% below fair value)
No single metric tells the full story. See the ROCO:6986 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.
42GF Score
Get the complete analysis for ROCO:6986
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6986 has been successfully added to your 
